Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature
NCT:NCT04674969 · RECRUITING
广告
NCT编号NCT04674969
状态RECRUITING
开始日期2021-03-29
SponsorBoston Scientific Corporation (INDUSTRY)
First posted
Last updated
简要摘要
The ELEGANCE Registry's objective is to collect Real-World Data (RWD), including populations previously not represented in Peripheral Vascular Disease (PVD) trials, health economics data, and to support the safe use of commercially available Boston Scientific Corporation (BSC) drug-eluting devices for the treatment of lesions located in the peripheral vasculature.
官方来源
在 ClinicalTrials.gov 上查看 →数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。